atai Life Sciences Advances Phase 1/2a Psilocin Trial for Depression
ELE-101, a novel intravenous (IV) formulation of psilocin, is being developed by atai Life Sciences to offer a rapid, reliable,... Lire la suite
June 22, 2024
Recently Published Articles
Discover how GrubMarket’s acquisition of Parsemony revolutionizes the food supply chain industry by enhancing software services and expanding enterprise AI capabilities. Join us in welcoming the future of food industry technology.
We are excited to announce that GrubMarket has acquired Parsemony, a leading provider of enterprise software for the fresh produce... Lire la suite
June 21, 2024
Discover how GrubMarket’s acquisition of Parsemony
GrubMarket Acquires Parsemony to Enhance Software Services for the Food Supply Chain Industry We are excited to announce that GrubMarket... Lire la suite
June 21, 2024
Discover how AI Orders revolutionizes order management for food
The Brkfst Club is excited to introduce AI Orders, a revolutionary AI-driven module that transforms the order intake process for... Lire la suite
June 8, 2024
atai Life Sciences to Join Jefferies Global Healthcare Conference 2024
atai Life Sciences, a NASDAQ-listed clinical-stage biopharmaceutical company, will be participating in the Jefferies Global Healthcare Conference in New York.... Lire la suite
June 4, 2024
Most Popular Articles
